University of Maryland Medical Center Greenebaum Comprehensive Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
University of Maryland Medical Center Greenebaum Comprehensive Cancer Center has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer, Advanced Non-squamous Non-small-cell Lung Cancer.
Sponsors: Daiichi Sankyo, Genelux Corporation.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Maryland Medical Center Greenebaum Comprehensive Cancer Center has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Maryland Medical Center Greenebaum Comprehensive Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer, Advanced Non-squamous Non-small-cell Lung Cancer.
University of Maryland Medical Center Greenebaum Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.